Contract Notice: Open House Contracts For Several Active Ingredients/Active Ingredient Combinations Pharmaceutical Products Short Description: The Subject Of This Publication Is The Conclusion Of Contracts According To 130A (8) Sgb V Via The Following Active Ingredients/Active Ingredient Combinations In The Context Of A So-Called Open House Procedure: Aprepitant (A04ad12) Only Packs With A Component Except The 80Mg N1 Form Bimatoprost (S01ee03) Budesonide (A07ea06, D07ac09, R01ad05, R03ba02) Without Inhalativa Clonazepam (N03ae01) Iron (Ii) Sulfate (B03aa07) Emtricitabine/Tenofovirdisoproxil/Rilpivirin (J05ar08) Hydroxychloroquin (P01ba02) Lenograstim (L03aa10) Nadroparin (B01ab06) Vildagliptin & Metformin (A10bd08) Under The Specification Of Uniform Contractual Conditions And Uniform Access Procedures, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Is Offered To Conclude A Discount Contract According To 130A (8) Sgb V Via The Active Ingredients/Combinations Of Active Ingredients. The Earliest Start Of The Contract Is 01.12.2022. Based On This, The Contract Term Is A Maximum Of 24 Months. Deadline For Submission: 20241007 17:00 Type Of Buyer: Body Governed By Public Law Type Of Contract: Supplies Type Of Procedure: Open Procedure Regulation: European Union Type Of Bid: Submission For All Lots Award Criteria: Lowest Price [Disclaimer: The Above Text Is Machine Translated. For Accurate Information Kindly Refer The Original Document.] Tender Link : Https://Ted.Europa.Eu/Udl?Uri=Ted:Notice:594454-2022:Data:En:Html
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 56819422
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.